Finance / Company Results

Merck Announces Q2 2025 Financial Results: Focus on Oncology and Animal Health

Merck (NYSE: MRK) released its Q2 2025 financial results, highlighting strong performance in oncology and animal health, alongside contributions from recent product launches. The company is strategically optimizing its portfolio to focus on...